Establishment of a recombinant phenotypic HIV-1 integrase susceptibility assay.
Resistance analysis of the integrase gene of patient-derived viruses in vitro.
Generation of resistance data after therapy failures from routine clinical practice.
Possibility to identify resistance patterns of recent integrase inhibitors.
Generation of additional genotype-phenotype pairs for geno2pheno[integrase].